Phillip
Carter

Founding Partner
Chief Executive Officer

➤ Over 25 years of experience advancing innovative therapies from concept to commercialization.
➤ Built and led high-performing teams at top pharma and biotech companies, launching first-in-class and blockbuster products across rare diseases, oncology, cell and gene, and other specialty markets.
➤ Strategic partner and trusted advisor to global healthcare organizations, private equity firms, and technology accelerators.
➤ Serves on Duke University's Healthcare Alumni Advisory Board.
➤ Holds an MBA from the Fuqua School of Business at Duke University.

Brent
Haynie

Partner
Chief Strategy Officer

➤ Over 25 years of experience leading product strategy and launching high-priority assets across primary, specialty, and acute care markets.
➤ Delivered multi-blockbuster products and managed large, high-value portfolios with significant budget responsibilities.
➤ Secured substantial development funding and closed multiple strategic deals.
➤ Extensive expertise in US public and private insurance segments, with a background in management consulting.
➤ Holds an MBA from the Wharton School of the University of Pennsylvania.

Barry
Evans

Partner
Chief Information Officer

➤ Over 24 years building and delivering cybersecurity sofware and solutions across multiple industries working in development, services, and director roles.
➤ Specialized in healthcare and fintech regulatory security requirements and integrations. Built goverance solutions to achieve licensing goals for organizations.
➤ Experience in both core enterprise and consumer facing (CIAM) security solutions including Governance, Risk, and Compliance (GRC) IT policies and auditing.
➤ Holds a Computer Science degree from the Engineering School at North Carolina State University